Evidence map›Paper›PMID 27079700›Full record

Observational studyJournal of Alzheimer's disease : JAD2016

Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.

Carsten Henneges, Catherine Reed, Yun-Fei Chen, Grazia Dell'Agnello, Jeremie Lebrec

Abstract readObservational Study
In one paragraph

Observational study in Journal of Alzheimer's disease : JAD, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Observational
  14. Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  15. Using artificial intelligence to learn optimal regimen plan for Alzheimer's disease.Journal of the American Medical Informatics Association : JAMIA · 2023
    Article
  16. Determinants of Attitude to a Humanoid Social Robot in Care for Older Adults: A Post-Interaction Study.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  17. Using Artificial Intelligence to Learn Optimal Regimen Plan for Alzheimer's Disease.medRxiv : the preprint server for health sciences · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carsten HennegesLilly Deutschland GmbH, Bad Homburg, Germany.
Catherine ReedEli Lilly and Company Limited, Lilly Research Centre, Windlesham, UK.
Yun-Fei ChenEli Lilly & Co., Indianapolis, USA.
Grazia Dell'AgnelloLilly Italia S.p.A. Sesto Fiorentino, (FI), Italy.
Jeremie LebrecLilly Deutschland GmbH, Bad Homburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImproved understanding of the pattern of cognitive decline in Alzheimer's disease (AD) would be useful to assist primary care physicians in explaining AD progression to patients and caregivers.

objectiveTo identify the sequence in which cognitive abilities decline in community-dwelling patients with AD.

methodsBaseline data were analyzed from 1,495 patients diagnosed with probable AD and a Mini-Mental State Examination (MMSE) score ≤ 26 enrolled in the 18-month observational GERAS study. Proportional odds logistic regression models were applied to model MMSE subscores (orientation, registration, attention and concentration, recall, language, and drawing) and the corresponding subscores of the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog), using MMSE total score as the index of disease progression. Probabilities of impairment start and full impairment were estimated at each MMSE total score level.

resultsFrom the estimated probabilities for each MMSE subscore as a function of the MMSE total score, the first aspect of cognition to start being impaired was recall, followed by orientation in time, attention and concentration, orientation in place, language, drawing, and registration. For full impairment in subscores, the sequence was recall, drawing, attention and concentration, orientation in time, orientation in place, registration, and language. The sequence of cognitive decline for the corresponding ADAS-cog subscores was remarkably consistent with this pattern.

conclusionThe sequence of cognitive decline in AD can be visualized in an animation using probability estimates for key aspects of cognition. This might be useful for clinicians to set expectations on disease progression for patients and caregivers.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseCaregiversCognition DisordersDisease ProgressionFemaleHumansLongitudinal StudiesMaleMental Status ScheduleMiddle AgedNeuropsychological TestsOdds RatioAlzheimer’s diseasecognitiondisease progressionobservational study

Identifiers

PMID27079700
PMCPMC4927893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.